Caduceus Software Systems, The Company, announces today that it is not going to merger with CEN Biotech.
We were not able to communicate anything during the merger due to respecting the quiet period.
Today, the CEN Biotech merger agreement has been cancelled. There is now new news:
1) There is no reverse split happening
2) There is no merger with CEN or its subsidiaries
3) CSOC is now alone and independent.
The intentions of the original merger was to give added value to the sharesholders. It was sincere and honest.
The cancellation was a result of the two Companies not being able to merge while keeping value to shareholders.
A notice was given by CEN to me, Richard Tang, that CEN terminates the agreement. It was sent today at 9AM PST.
We sincere wish to add value to CSOC and give our loyal shareholders value. We are open to ideas, mergers, acquisitions, and joint ventures.
We are sorry for being out of touch with our shareholders. We will use twitter and from time to time, IHUB (if IHUB doesn't lock us out again).
Please note that we may not be able to pay for the OTCMarkets yearly fee, because it was paid in part by CEN, so the stock may go from Pink Current to Yield and then to STOP. This has very little effect on our operations, since we are not going to deposit and sell any stock. Business and financials are predicted to be near and similar to the previous quarters and annual filed.
If we have any more updates, please find us on twitter. Email is info@caduceussoftware.net
I give a sincere thank you to all of our loyal shareholders. And I hope that this NON merger news gives good reprieve on the downward and negative pressure of CSOC as there was a insinuation of a bad reverse split that is bad for CSOC shareholders. This is not going to happen as the merger is dead.
Thank you and happy thanksgiving, best wishes for the upcoming holidays
Sincerely,
Richard Tang, Anna Tang, Erwin Vahlsing